Is Nuclear Cell-Free DNA the "Must-Have" for Risk Stratification in Congenital Heart Surgery?
- PMID: 36521529
- DOI: 10.1016/j.athoracsur.2022.12.008
Is Nuclear Cell-Free DNA the "Must-Have" for Risk Stratification in Congenital Heart Surgery?
Comment on
-
Nuclear Cell-Free DNA Predicts Adverse Events After Pediatric Cardiothoracic Surgery.Ann Thorac Surg. 2023 Aug;116(2):349-356. doi: 10.1016/j.athoracsur.2022.10.027. Epub 2022 Nov 1. Ann Thorac Surg. 2023. PMID: 36332680
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical